Yeming Wu
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
Papers in
- Neurology 17
- Neuroblastoma Research and Treatments 16
-
- Ubiquitin and proteasome pathways 5
- Signaling Pathways in Disease 3
- Cell death mechanisms and regulation 3
- Co-authors
- Minjia Tan (2 shared papers)Yingming Zhao (2 shared papers)Lunzhi Dai (2 shared papers)Zhongyu Xie (1 shared paper)Zhongyi Cheng (1 shared paper)Junbiao Dai (1 shared paper)Jef D. Boeke (1 shared paper)Zhixiang Wu (13 shared papers)
- Journals
- Cell Death and Disease (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)British Journal of Cancer (1 paper)International Journal of Medical Sciences (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yeming Wu
30 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Geriatrics and Gerontology 104
- Pharmaceutical Science 84
- Cancer Research 159
- Molecular Biology 675
- Neurology 88
Countries citing papers authored by Yeming Wu
This map shows the geographic impact of Yeming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeming Wu more than expected).
Fields of papers citing papers by Yeming Wu
This network shows the impact of papers produced by Yeming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeming Wu. The network helps show where Yeming Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yeming Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lysine Succinylation and Lysine Malonylation in Histones Hit paper breakdown → | 2012 | 484 |
| 2 | 2015 | 71 | |
| 3 | 2016 | 70 | |
| 4 | 2017 | 69 | |
| 5 | 2015 | 47 | |
| 6 | 2018 | 38 | |
| 7 | 2014 | 35 | |
| 8 | 2018 | 34 | |
| 9 | 2022 | 31 | |
| 10 | 2021 | 19 | |
| 11 | 2020 | 18 | |
| 12 | 2013 | 16 | |
| 13 | 2018 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2016 | 12 | |
| 17 | 2014 | 9 | |
| 18 | 2013 | 7 | |
| 19 | 2017 | 7 | |
| 20 | 2017 | 6 |
About Yeming Wu
Yeming Wu is a scholar working on Neurology, Molecular Biology, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (8 papers), Ubiquitin and proteasome pathways (5 papers), Signaling Pathways in Disease (3 papers), Lung Cancer Research Studies (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Cell death mechanisms and regulation (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Geriatrics and Gerontology (104 citations), Pharmaceutical Science (84 citations), Cancer Research (159 citations), Molecular Biology (675 citations) and Neurology (88 citations). Yeming Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Minjia Tan, Yingming Zhao, Lunzhi Dai, Zhongyu Xie, Zhongyi Cheng, Junbiao Dai, Jef D. Boeke, Zhixiang Wu, Qiu-Dong Jiang and Pei Liu. Their work appears in journals such as Cell Death and Disease, Journal of Experimental & Clinical Cancer Research, Journal of Clinical Oncology, British Journal of Cancer and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.